Entrada Therapeutics is finally able to get its Duchenne muscular dystrophy candidate (DMD) back on track after the FDA ...
8h
Entrada Therapeutics gains FDA clearance for its Phase 1b ELEVATE-44-102 study, evaluating ENTR-601-44 in adult Duchenne ...
In a report released today, Boobalan Pachaiyappan from Roth MKM reiterated a Buy rating on Entrada Therapeutics Inc (TRDA – Research Report), ...
Receives FDA authorization to initiate ELEVATE-44-102, a Phase 1b multiple ascending dose clinical study of ENTR-601-44 in adults living with Duchenne muscular dystrophy - - Follows recently received ...
Shares of Entrada Therapeutics rose after regulators removed a clinical hold and said its lead product candidate could be studied as a treatment for Duchenne muscular dystrophy. The stock was up 9.5% ...
Entrada Therapeutics (TRDA) announced that the United States Food and Drug Administration has lifted the clinical hold on ENTR-601-44 and ...
Receives FDA authorization to initiate ELEVATE-44-102, a Phase 1b multiple ascending dose clinical study of ENTR-601-44 in adults living with Duchenne muscular dystrophy – – Follows recently received ...
WASHINGTON — After nearly three years operating in stealth mode, Seattle-based startup Kapta Space emerged on Feb. 21, announcing plans to demonstrate metasurface antenna technology for space-based ...
Kapta Space, a Seattle-based space tech startup, today came out of stealth mode and announced that it has raised a $5 million seed round to support the development of its advanced spaceborne ...
Kapta Space plans to innovate space radar technology, enhancing precision and reducing imaging costs with electronically ...
Oswaldo Rivas Reubicarán la Entrada Peatonal de la Garita de Calexico ...
El cuerpo del hombre fue encontrado cerca de un área donde se informó que un kayakista desapareció el viernes pasado en ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback